Aethlon Medical, Inc. (NASDAQ:AEMD) Short Interest Up 454.0% in June

Aethlon Medical, Inc. (NASDAQ:AEMD) was the target of a large increase in short interest during the month of June. As of June 15th, there was short interest totalling 2,510,000 shares, an increase of 454.0% from the May 31st total of 453,100 shares. Based on an average daily volume of 4,190,000 shares, the short-interest ratio is currently 0.6 days. Currently, 29.2% of the company’s shares are short sold.

Aethlon Medical Stock Down 13.8 %

Shares of NASDAQ AEMD opened at $0.50 on Friday. The stock has a market cap of $1.31 million, a PE ratio of -0.10 and a beta of 1.60. Aethlon Medical has a 52-week low of $0.37 and a 52-week high of $5.00. The business has a 50-day moving average price of $0.78 and a 200 day moving average price of $1.44.

Analysts Set New Price Targets

Several brokerages have recently commented on AEMD. HC Wainwright decreased their price target on Aethlon Medical from $10.00 to $7.00 and set a “buy” rating on the stock in a research note on Monday, June 24th. StockNews.com initiated coverage on Aethlon Medical in a research note on Sunday, June 23rd. They set a “sell” rating on the stock.

Aethlon Medical Company Profile

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.